title: Robust generation of oligodendrocyte progenitors from human neural stem cells and engraftment in experimental demyelination models in mice.
abstract: BACKGROUND
  Cell-based therapy holds great promises for demyelinating diseases. Human-derived fetal and adult oligodendrocyte progenitors (OPC) gave encouraging results in experimental models of dysmyelination but their limited proliferation in vitro and their potential immunogenicity might restrict their use in clinical applications. Virtually unlimited numbers of oligodendroglial cells could be generated from long-term self-renewing human (h)-derived neural stem cells (hNSC). However, robust oligodendrocyte production from hNSC has not been reported so far, indicating the need for improved understanding of the molecular and environmental signals controlling hNSC progression through the oligodendroglial lineage. The aim of this work was to obtain enriched and renewable cultures of hNSC-derived oligodendroglial cells by means of epigenetic manipulation.
  
  
  RESULTS
  We report here the generation of large numbers of hNSC-derived oligodendroglial cells by concurrent/sequential in vitro exposure to combinations of growth factors (FGF2, PDGF-AA), neurotrophins (NT3) and hormones (T3). In particular, the combination FGF2+NT3+PDGF-AA resulted in the maintenance and enrichment of an oligodendroglial cell population displaying immature phenotype (i.e., proliferation capacity and expression of PDGFRalpha, Olig1 and Sox10), limited self-renewal and increased migratory activity in vitro. These cells generate large numbers of oligodendroglial progeny at the early stages of maturation, both in vitro and after transplantation in models of CNS demyelination.
  
  
  CONCLUSIONS
  We describe a reliable method to generate large numbers of oligodendrocytes from a renewable source of somatic, non-immortalized NSC from the human foetal brain. We also provide insights on the mechanisms underlying the pro-oligodendrogenic effect of the treatments in vitro and discuss potential issues responsible for the limited myelinating capacity shown by hNSC-derived oligodendrocytes in vivo.
authors.affiliation: San Raffaele Scientific Institute, San Raffaele Telethon Institute for Gene Therapy (HSR-TIGET), Milano, Italy.
authors.forename: Margherita
authors.initials: M
authors.lastname: Neri
authors.forename: Claudio
authors.initials: C
authors.lastname: Maderna
authors.forename: Daniela
authors.initials: D
authors.lastname: Ferrari
authors.forename: Chiara
authors.initials: C
authors.lastname: Cavazzin
authors.forename: Angelo L
authors.initials: AL
authors.lastname: Vescovi
authors.forename: Angela
authors.initials: A
authors.lastname: Gritti
mesh_terms: D000818:Animals; D018929:Cell Culture Techniques; D003711:Demyelinating Diseases / Q000628:therapy*; D006085:Graft Survival; D006801:Humans; D051379:Mice; D023421:Models, Animal; D039902:Multipotent Stem Cells / Q000166:cytology; D009474:Neurons / Q000166:cytology; D009836:Oligodendroglia / Q000166:cytology / Q000637:transplantation*; D033581:Stem Cell Transplantation / Q000379:methods*; D014183:Transplantation, Heterologous
references.citation: Nat Biotechnol. 1998 Nov;16(11):1033-9
references.pmid: 9831031
references.citation: PLoS One. 2008 Oct 02;3(10):e3310
references.pmid: 18836552
references.citation: Glia. 2006 Jan 15;53(2):167-81
references.pmid: 16206164
references.citation: Stem Cells. 2007 Sep;25(9):2312-21
references.pmid: 17556596
references.citation: Cell Stem Cell. 2007 Jun 7;1(1):39-49
references.pmid: 18371333
references.citation: J Neurosci Res. 1999 Aug 1;57(3):304-14
references.pmid: 10412021
references.citation: Curr Biol. 2003 Jan 21;13(2):151-5
references.pmid: 12546790
references.citation: Neurochem Res. 2007 Apr-May;32(4-5):783-97
references.pmid: 17186374
references.citation: J Cell Biol. 2004 Jan 5;164(1):111-22
references.pmid: 14709544
references.citation: Neurosci Lett. 2009 Jun 12;456(3):112-9
references.pmid: 19429145
references.citation: J Neurosci Res. 2009 Nov 15;87(15):3438-46
references.pmid: 19739249
references.citation: Exp Cell Res. 2006 Jul 1;312(11):2107-20
references.pmid: 16631163
references.citation: Nat Neurosci. 2008 Dec;11(12):1392-401
references.pmid: 18849983
references.citation: Proc Natl Acad Sci U S A. 2005 Sep 27;102(39):14069-74
references.pmid: 16172374
references.citation: Proc Natl Acad Sci U S A. 2000 Dec 19;97(26):14720-5
references.pmid: 11121071
references.citation: Curr Opin Neurol. 2008 Jun;21(3):278-83
references.pmid: 18451710
references.citation: J Neurosci. 1999 Nov 15;19(22):9986-95
references.pmid: 10559406
references.citation: J Neurosci Res. 2002 Sep 15;69(6):976-86
references.pmid: 12205691
references.citation: PLoS One. 2007 Aug 01;2(8):e689
references.pmid: 17668067
references.citation: Gene Ther. 2006 Mar;13(5):379-88
references.pmid: 16355116
references.citation: J Neurosci Res. 1992 Aug;32(4):494-506
references.pmid: 1356158
references.citation: Int J Dev Neurosci. 2009 Dec;27(8):769-78
references.pmid: 19720126
references.citation: Nature. 1994 Jan 27;367(6461):371-5
references.pmid: 8114937
references.citation: J Neurosci Res. 2002 Sep 15;69(6):966-75
references.pmid: 12205690
references.citation: J Neurobiol. 1999 Sep 15;40(4):497-512
references.pmid: 10453052
references.citation: Glia. 2004 Sep;47(4):314-24
references.pmid: 15293229
references.citation: Genes Dev. 2002 Jan 15;16(2):165-70
references.pmid: 11799060
references.citation: Proc Natl Acad Sci U S A. 2006 May 16;103(20):7853-8
references.pmid: 16682644
references.citation: J Neurosci. 2009 Jun 17;29(24):7649-57
references.pmid: 19535576
references.citation: Nature. 1988 Jun 9;333(6173):560-2
references.pmid: 3287176
references.citation: Mol Cell Neurosci. 2000 Oct;16(4):422-39
references.pmid: 11085879
references.citation: Nat Med. 2004 Jan;10(1):93-7
references.pmid: 14702638
references.citation: Proc Natl Acad Sci U S A. 2004 Aug 10;101(32):11839-44
references.pmid: 15280535
references.citation: Stem Cells Dev. 2009 Sep;18(7):1043-58
references.pmid: 19327007
references.citation: Cell. 1992 Jul 10;70(1):31-46
references.pmid: 1623522
references.citation: Neuroscience. 2007 Aug 24;148(2):535-40
references.pmid: 17681700
references.citation: J Comp Neurol. 2004 Jul 19;475(2):211-9
references.pmid: 15211462
references.citation: Neuropathol Appl Neurobiol. 1996 Jun;22(3):199-206
references.pmid: 8804021
references.citation: Cell Stem Cell. 2008 Jun 5;2(6):553-65
references.pmid: 18522848
references.citation: Glia. 2005 May;50(3):212-22
references.pmid: 15712210
references.citation: Glia. 2003 Nov;44(2):153-65
references.pmid: 14515331
references.citation: Exp Neurol. 1999 Aug;158(2):265-78
references.pmid: 10415135
references.citation: Mol Cell Neurosci. 1996 Aug;8(2/3):146-56
references.pmid: 8954629
references.citation: Dev Neurosci. 2001;23(4-5):327-37
references.pmid: 11756748
references.citation: Nat Biotechnol. 1998 Nov;16(11):1040-4
references.pmid: 9831032
references.citation: Ann Neurol. 2009 Sep;66(3):343-54
references.pmid: 19798728
references.citation: Clin Pharmacol Ther. 2007 Oct;82(4):453-60
references.pmid: 17713467
references.citation: J Neurosci. 1992 Apr;12(4):1538-47
references.pmid: 1556607
references.citation: J Neurosci. 2008 Oct 8;28(41):10434-42
references.pmid: 18842903
references.citation: Nat Cell Biol. 2002 Nov;4(11):833-41
references.pmid: 12379866
references.citation: Curr Opin Neurol. 2007 Dec;20(6):688-92
references.pmid: 17992090
references.citation: EMBO J. 2002 Dec 2;21(23):6452-60
references.pmid: 12456652
references.citation: Stem Cells. 2009 Jan;27(1):116-25
references.pmid: 18403757
references.citation: J Comp Neurol. 2009 Nov 20;517(3):333-49
references.pmid: 19760739
references.citation: PLoS One. 2007 Jan 17;2(1):e156
references.pmid: 17225860
references.citation: Exp Neurol. 1999 Mar;156(1):71-83
references.pmid: 10192778
references.citation: J Neurosci. 2004 Apr 14;24(15):3816-25
references.pmid: 15084663
references.citation: Neuron. 1998 May;20(5):869-82
references.pmid: 9620692
references.citation: J Neurosci. 2002 Jan 15;22(2):437-45
references.pmid: 11784788
references.citation: Brain Pathol. 1999 Jul;9(3):499-513
references.pmid: 10416990
references.citation: Development. 2003 Dec;130(26):6599-609
references.pmid: 14660548
references.citation: J Neurotrauma. 1999 Aug;16(8):689-93
references.pmid: 10511241
references.citation: J Neurosci. 1999 Jul 15;19(14):5990-6005
references.pmid: 10407037
references.citation: Nat Biotechnol. 2001 May;19(5):475-9
references.pmid: 11329020
references.citation: Nat Med. 2003 Apr;9(4):439-47
references.pmid: 12627226
references.citation: Glia. 2002 Oct;40(1):65-77
references.pmid: 12237844
references.citation: Development. 2008 Feb;135(4):637-46
references.pmid: 18184726
references.citation: Glia. 2006 Jul;54(1):35-46
references.pmid: 16673374
references.citation: Mol Cell Neurosci. 2008 Jun;38(2):245-58
references.pmid: 18450476
references.citation: J Neurosci Res. 1997 Oct 15;50(2):146-56
references.pmid: 9373025
references.citation: J Neurosci Res. 2000 Feb 1;59(3):421-9
references.pmid: 10679779
references.citation: Rejuvenation Res. 2005 Fall;8(3):131-4
references.pmid: 16144466
references.citation: Nat Neurosci. 2002 Dec;5(12):1271-8
references.pmid: 12426573